TRAFALGAR MEDICAL GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: J82028 | SOUTHSEA, PO5 3ND
Showing results 101-150 of 794
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Budesonide | 910 | 1,462 | £37.7K | +67.9% ▲ |
| Promethazine hydrochloride | 910 | 44.8K | £4.8K | +154.6% ▲ |
| Memantine hydrochloride | 908 | 22.7K | £3.9K | +174.9% ▲ |
| Atenolol | 890 | 51.4K | £1.2K | +47.6% ▲ |
| Lactulose | 884 | 525.6K | £4.9K | +168.5% ▲ |
| Estriol | 848 | 19.9K | £9.0K | +298.5% ▲ |
| 824 | 57.4K | £17.8K | +1,931.6% ▲ | |
| Isosorbide mononitrate | 816 | 29.6K | £4.0K | +23.5% ▲ |
| Felodipine | 816 | 42.3K | £6.7K | +37.4% ▲ |
| Sitagliptin | 811 | 29.1K | £2.1K | +107.9% ▲ |
| Montelukast | 802 | 34.1K | £1.7K | +17.1% ▲ |
| 789 | 1,204 | £53.2K | +154.0% ▲ | |
| Sodium valproate | 777 | 84.8K | £12.2K | +144.3% ▲ |
| Carbocisteine | 771 | 79.3K | £1.9K | +44.4% ▲ |
| 771 | 9,921 | £5.8K | +654.7% ▲ | |
| Hyoscine butylbromide | 770 | 59.0K | £4.6K | +230.4% ▲ |
| Mometasone furoate | 769 | 43.7K | £4.2K | +475.1% ▲ |
| Betamethasone valerate | 761 | 62.0K | £5.2K | +97.7% ▲ |
| Loperamide hydrochloride | 752 | 69.4K | £1.8K | +222.9% ▲ |
| Procyclidine hydrochloride | 752 | 26.0K | £1.2K | +431.6% ▲ |
| Eplerenone | 745 | 26.1K | £3.2K | +180.9% ▲ |
| Clonazepam | 725 | 27.8K | £4.9K | +365.3% ▲ |
| Isophane insulin | 722 | 4,724 | £20.4K | +583.9% ▲ |
| Mirabegron | 717 | 25.7K | £23.6K | +78.5% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 702 | 53.0K | £2.1K | +129.1% ▲ |
| Ezetimibe | 679 | 32.9K | £5.7K | -4.6% ▼ |
| 679 | 95.9K | £3.5K | +43.1% ▲ | |
| Mesalazine (Systemic) | 670 | 77.5K | £47.9K | +179.7% ▲ |
| Insulin aspart | 660 | 4,289 | £28.4K | +73.3% ▲ |
| Donepezil hydrochloride | 651 | 14.4K | £813 | +111.0% ▲ |
| 635 | 8,127 | £3.1K | +154.5% ▲ | |
| Clarithromycin | 629 | 13.1K | £2.9K | +156.4% ▲ |
| 627 | 685 | £3.7K | +165.4% ▲ | |
| Gliclazide | 624 | 44.0K | £3.6K | -26.7% ▼ |
| Nebivolol | 619 | 19.9K | £3.2K | +484.0% ▲ |
| Pravastatin sodium | 617 | 30.0K | £1.4K | +90.0% ▲ |
| Umeclidinium bromide/vilanterol | 613 | 945 | £29.2K | +214.4% ▲ |
| Methotrexate | 609 | 15.3K | £6.7K | +87.1% ▲ |
| Methylphenidate hydrochloride | 608 | 19.8K | £20.9K | +135.4% ▲ |
| 603 | 77.0K | £2.2K | +118.1% ▲ | |
| Estradiol | 601 | 16.6K | £7.9K | +122.8% ▲ |
| Fluticasone propionate (Inhalation) | 585 | 1,010 | £22.4K | +51.2% ▲ |
| Lorazepam | 579 | 12.1K | £3.5K | +306.2% ▲ |
| Clobetasol propionate | 572 | 38.4K | £3.0K | +319.2% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 569 | 63.5K | £4.7K | +151.8% ▲ |
| Prochlorperazine maleate | 563 | 28.6K | £1.8K | +178.5% ▲ |
| Insulin degludec | 563 | 4,070 | £40.4K | +412.3% ▲ |
| Fluticasone/umeclidinium/vilanterol | 558 | 866 | £36.6K | +138.0% ▲ |
| Tadalafil | 555 | 9,360 | £2.7K | +226.4% ▲ |
| Risperidone | 539 | 26.3K | £5.0K | +113.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.